1. Scherlag BJ, Lau SH, Helfant RH, et al. Catheter technique for recording His bundle activity in man. Circulation39:13-13, 1969
2.
2. Durrer D, Schoo L, Schuilenburg RM, et al. The role of premature beats in the initiation and the termination of supraventricular tachycardias in the W.P.W syndrome. Circulation36:644-644, 1967
3.
3. Wellens HJJ. Electrical Stimulation of the Heart in the Study and Treatment of Tachycardias. Baltimore, University Park Press, 1971
4.
4. Wu D, Wyndham CR, Denes P, et al. Chronic electrophysiological study in patients with recurrent paroxysmal tachycardia: A new method for developing successful oral antiarrhythmic therapy. In Kulbertus H (ed). Re-entrant Arrhythmias: Mechanisms and Treatment. University Park Press, Baltimore, 1976
5.
5. Hartzler GO, Maloney JD. Programmed ventricular stimulation in management of recurrent ventricular tachycardia. Mayo Clin52:731-741, 1977
6.
6. Fisher JD, Cohen HL, Mehra R, et al. Cardiac pacing and pacemakers II. Serial electrophysiologic-pharmacologic testing for control of recurrent tachyarrhythmias. Am Heart J93:658-668, 1977
7.
7. Mason JW, Winkle RA. Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia. Circulation58:971-985, 1978
8.
8. Horowitz LN, Josephson ME, Farshidi A, et al. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens. Circulation58:986-997, 1978
9.
9. Friedman L, Yusuf S. Does therapy directed by programmed electrical stimulation provide a satisfactory clinical response?Circulation73:II-59-66, 1986
10.
10. Woosley RL. The role of programmed electrical stimulation in the evaluation of investigational antiarrhythmic drugs: Overview of the workshop. Circulation73:II-112-113, 1986
11.
11. Lown B, Graboys TB, Podrid PJ, et al. Historic perspectives-electrical stimulation of the heart. Circulation73:II-3-10, 1986
12.
12. Gaboys TB, Lown B, Podrid PHJ, et al. Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs. Am J Cardiol50:437-443, 1982
13.
13. Mitchell BL, Duff HJ, Manyari DE, et al. A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia. N Engl J Med317:1681-1687, 1987
14.
14. Mason JW for the ESVEM investigators. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. N Engl J Med329:445-451, 1993
15.
15. Mitchell BL, Sheldon RS, Gillis AM, et al. Definition of predicted effective antiarrhythmic drug therapy for ventricular tachyarrhythmias by the electrophysiologic study approach: Randomized comparison of patient response criteria. J Am Coll Cardiol30:1346-1353, 1997
16.
16. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N EngI J Med341:1882-1890, 1999
17.
17. Moss AJ, Hall WJ, Cannom IDS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med3351:1933-1940, 1996
